14 results  1 of 1 

1 Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin’s Lymphoma: A Multicenter Randomized Phase II Study by the Consortium for Improving Survival of Lymphoma (CISL)
Kyoung Ha Kim, Jae Hoon Lee, Mark Lee, Hoon-Gu Kim, Young Rok Do, Yong Park, Sung Yong Oh, Ho-Jin Shin, Won Seog Kim, Seong Kyu Park, Jee Hyun Kong, Moo-Rim Park, Deok-Hwan Yang, Jae-Yong Kwak, Hye Jin Kang, Yeung-Chul Mun, Jong-Ho Won
Cancer Res Treat.2023;55(1):304-313.   Published online 2022 March 30     DOI: http://dx.doi.org/10.4143/crt.2022.004
      
2 Establishment of Effective Mouse Model of Premature Ovarian Failure Considering Treatment Duration of Anticancer Drugs and Natural Recovery Time
Eun hee Lee, Si Eun Han, Min Jung Park, Hyeon Jung Kim, Hwi Gon Kim, Chang Woon Kim, Bo Sun Joo, Kyu Sup Lee
J Menopausal Med.2018;24(3):196-203.   Published online 2018 December 31     DOI: http://dx.doi.org/10.6118/jmm.2018.24.3.196
      
3 Busulfan plus melphalan versus high-dose melphalan as conditioning regimens in autologous stem cell transplantation for newly diagnosed multiple myeloma
Ja Min Byun, Jayoun Lee, Sang-Jin Shin, Minjoo Kang, Sung-Soo Yoon, Youngil Koh
Blood Res.2018;53(2):105-109.   Published online 2018 June 25     DOI: http://dx.doi.org/10.5045/br.2018.53.2.105
      
4 Application of stereological methods for unbiased estimation of sperm morphology in the mice induced by busulfan
Sakineh Panahi, Mohammad-Amin Abdollahifar, Abbas Aliaghaei, Hamid Nazarian, Shahrokh Paktinat, Shabnam Abdi, Reza Mastery Farahani
Anat Cell Biol.2017;50(4):301-305.   Published online 2017 December 29     DOI: http://dx.doi.org/10.5115/acb.2017.50.4.301
      
5 Dose-dependent effects of busulfan on dog testes in preparation for spermatogonial stem cell transplantation
Tai-Young Hur, Seung-Hoon Lee, Sun-A Ock, Hyuk Song, Hyun-Jung Park, Ran Lee, Si-Heung Sung, Hyunjhung Jhun, Won-Young Lee
Lab Anim Res.2017;33(3):264-269.   Published online 2017 September 27     DOI: http://dx.doi.org/10.5625/lar.2017.33.3.264
      
6 Prospective validation of a novel dosing scheme for intravenous busulfan in adult patients undergoing hematopoietic stem cell transplantation
Sang-Heon Cho, Jung-Hee Lee, Hyeong-Seok Lim, Kyoo-Hyung Lee, Dae-Young Kim, Sangmin Choe, Kyun-Seop Bae, Je-Hwan Lee
Korean J Physiol Pharmacol.2016;20(3):245-251.   Published online 2016 April 26     DOI: http://dx.doi.org/10.4196/kjpp.2016.20.3.245
      
7 Humanizing NOD/SCID/IL-2Rγnull (NSG) mice using busulfan and retro-orbital injection of umbilical cord blood-derived CD34+ cells
Young Kyung Kang, Yunmi Ko, Aery Choi, Hyeong Jwa Choi, Jin-Hee Seo, Minyoung Lee, Jun Ah Lee
Blood Res.2016;51(1):31-36.   Published online 2016 March 25     DOI: http://dx.doi.org/10.5045/br.2016.51.1.31
      
8 Induction of Spermatogenesis by Bone Marrow-derived Mesenchymal Stem Cells in Busulfan-induced Azoospermia in Hamster
Amin Tamadon, Davood Mehrabani, Farhad Rahmanifar, Alireza Raayat Jahromi, Mohadeseh Panahi, Shahrokh Zare, Zahra Khodabandeh, Iman Razeghian Jahromi, Nader Tanideh, Mehdi Dianatpour, Mani Ramzi, Omid Koohi-Hoseinabadi
Int J Stem Cells.2015;8(2):134-145.   Published online 2015 November 30     DOI: http://dx.doi.org/10.15283/ijsc.2015.8.2.134
      
9 Quantification of Human Plasma-Busulfan Concentration by Liquid Chromatography-Tandem Mass Spectrometry
Soo Young Moon, Min Kyoo Lim, Susie Hong, Yongbum Jeon, Minje Han, Sang Hoon Song, Kyoung Soo Lim, Kyung-Sang Yu, In-Jin Jang, Ji Won Lee, Hyoung Jin Kang, Junghan Song
Ann Lab Med.2014;34(1):7-14.   Published online 2013 December 6     DOI: http://dx.doi.org/10.3343/alm.2014.34.1.7
      
10 A Simple Dosing Scheme for Intravenous Busulfan Based on Retrospective Population Pharmacokinetic Analysis in Korean Patients
Sangmin Choe, Gayeong Kim, Hyeong-Seok Lim, Sang-Heon Cho, Jong-Lyul Ghim, Jin Ah Jung, Un-Jib Kim, Gyujeong Noh, Kyun-Seop Bae, Dongho Lee
Korean J Physiol Pharmacol.2012;16(4):273-280.   Published online 2012 August 10     DOI: http://dx.doi.org/10.4196/kjpp.2012.16.4.273
      
11 Fludarabine-based myeloablative regimen as pretransplant conditioning therapy in adult acute leukemia/myelodysplastic syndrome: comparison with oral or intravenous busulfan with cyclophosphamide
Ji Hyun Lee, Jimin Choi, Kyung A Kwon, Suee Lee, Sung Yong Oh, Hyuk-Chan Kwon, Hyo-Jin Kim, Jin Yeong Han, Sung-Hyun Kim
Korean J Hematol.2010;45(2):102-108.   Published online 2010 June 30     DOI: http://dx.doi.org/10.5045/kjh.2010.45.2.102
      
12 The Effectiveness of Once-daily Intravenous Busulfan as a Conditioning Regime for Hematopoietic Stem Cell Transplantation in Children with Acute Myelogenous Leukemia
Seong Shik Park, Jeong Won Kwak, Young Tak Lim
Korean J Hematol.2009;44(1):1-7.   Published online 2009 March 20     DOI: http://dx.doi.org/10.5045/kjh.2009.44.1.1
   
13 Unrelated Bone Marrow Transplantation with a Reduced Toxicity Myeloablative Conditioning Regimen in Wiskott-Aldrich Syndrome
Hyoung Jin Kang, Hee Young Shin, Sun Hie Ko, Jeong Ah Park, Eun Kyung Kim, Jung Woo Rhim, Joong Gon Kim, Hyo Seop Ahn
J Korean Med Sci.2008;23(1):146-148.   Published online 2008 February 20     DOI: http://dx.doi.org/10.3346/jkms.2008.23.1.146
      
14 IL-2 Pathway Blocking in Combination with Anti-CD154 Synergistically Establishes Mixed Macrochimerism with Limited Dose of Bone Marrow Cells and Prolongs Skin Graft Survival in Mice
Jeong-hoon Lee, Jongwon Ha, Shi-hwa Kim, Sang Joon Kim
J Korean Med Sci.2006;21(6):1005-1011.   Published online 2006 December 31     DOI: http://dx.doi.org/10.3346/jkms.2006.21.6.1005
      

 1 of 1